Research carried out in the United States on prior cancer among persons newly diagnosed with cancer revealed that a significant percentage of patients who were diagnosed with the incident disease had survived a prior one. The Surveillance, Epidemiology and End Results (SEER) sequence numbers were used to derive the prevalence of preceding cancers. The categories of incident cancers included; first or only primary, higher primary or second order in the same cancer type and lastly, second order or higher primary in a different cancer spot.
A study of 740,990 cancer patients showed that about 11% of younger adults had survived prior cancer. The percentage was even higher in adults of over 65 years that is 25%. Another important observation is that most patients’ diagnosis revealed a different cancer type from the former site. The prevalence of preceding cancer was between 3.5% and 36.9% depending on the incident type and age. 18.4% of the 765,843 incident cancers diagnosed as from 2009 to 2013 epitomized a higher primary cancerous tumor or second order.
However, there is limited knowledge on survivor’s needs and treatments. Therefore, it is essential for medics to have a satisfactory understanding of the nature and effect of preceding cancer to enhance clinical trial accrual and generalizability.
Eric Lefkofsky is the co-founder and Chief Executive Officer of Tempus. The company was formed in 2016. Tempus is a technology company that invested heavily in creating the infrastructure to advance cancer treatment. The health tech aids physicians to make decisions that are data-driven, real-time and customized. Lefkofsky through his company Tempus has contributed significantly to developing better treatments and care plan for patients.
Entrepreneur Eric is also the co-founder of Echo Global Logistics, Uptake, Mediaocean, Lightbank, and InnerWorkings. He is also the co-founder and chairman of Groupon which is a global e-commerce marketplace. Lefkofsky also has a great passion for philanthropy and has contributed millions of dollars towards cancer research. In 2006 he together with his wife founded the Lefkofsky Foundation which is a charitable trust that funds other organizations.
Lefkofsky graduated with a law degree from the University of Michigan in 1993.